Author:
Keltner Norman L.,Johnson Vicki
Subject
General Medicine,Phychiatric Mental Health
Reference7 articles.
1. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors;Burris;Journal of Pharmacology and Experimental Therapeutics,2002
2. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor;Jordan;European Journal of Pharmacology,2002
3. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder;Kane;Journal of Clinical Psychiatry,2002
4. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, Part I: ‘Goldilocks’ actions at dopamine receptors;Stahl;Journal of Clinical Psychiatry,2001a
5. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics. Part II: Illustrating their mechanism of action;Stahl;Journal of Clinical Psychiatry,2001b
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献